These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 33723714)
1. Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study. Woelber L; Bommert M; Harter P; Prieske K; Zu Eulenburg C; Jueckstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Mahner S; Jaeger A Ann Surg Oncol; 2021 Oct; 28(11):6696-6704. PubMed ID: 33723714 [TBL] [Abstract][Full Text] [Related]
2. Pelvic lymphadenectomy in vulvar cancer and its impact on prognosis and outcome. Jaeger A; Prieske K; Mathey S; Fischer I; Vettorazzi E; Kuerti S; Reuter S; Dieckmann J; Schmalfeldt B; Woelber L Arch Gynecol Obstet; 2022 Jan; 305(1):233-240. PubMed ID: 34387725 [TBL] [Abstract][Full Text] [Related]
3. Number of Nodes Removed With Inguinofemoral Lymphadenectomy and Risk of Isolated Groin Recurrence in Women With FIGO Stage IB-II Squamous Cell Vulvar Cancer. Sopracordevole F; Clemente N; Giorda G; Canzonieri V; Alessandrini L; Del Fabro A; Serri M; Ciavattini A Int J Gynecol Cancer; 2018 Oct; 28(8):1600-1605. PubMed ID: 30036227 [TBL] [Abstract][Full Text] [Related]
4. The role of preoperative computerized tomography (CT) scan of the pelvis and groin in the management of clinically early staged vulva squamous cell carcinoma. Pounds R; O'Neill D; Subba K; Garg A; Scerif M; Leong E; Nevin J; Kehoe S; Yap J Gynecol Oncol; 2020 May; 157(2):444-449. PubMed ID: 31987600 [TBL] [Abstract][Full Text] [Related]
5. Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer. van Beekhuizen HJ; Auzin M; van den Einden LC; de Hullu JA; van der Velden J; Wildhagen MF; van Doorn HC Int J Gynecol Cancer; 2014 May; 24(4):773-8. PubMed ID: 24662136 [TBL] [Abstract][Full Text] [Related]
6. The number of removed lymph nodes by inguinofemoral lymphadenectomy: impact on recurrence rates in patients with vulva carcinoma. Diehl A; Volland R; Kirn V; Thangarajah F; Eichler C; Einzmann T; Wirtz M; Ratiu D; Morgenstern B; Fridrich C; Mallmann P; Puppe J Arch Gynecol Obstet; 2016 Jul; 294(1):131-6. PubMed ID: 26498758 [TBL] [Abstract][Full Text] [Related]
7. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma. Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039 [TBL] [Abstract][Full Text] [Related]
8. Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense? Woelber L; Bommert M; Prieske K; Fischer I; Zu Eulenburg C; Vettorazzi E; Harter P; Jueckstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Wimberger P; Hanker L; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Mahner S; Schmalfeldt B; Jaeger A Geburtshilfe Frauenheilkd; 2020 Dec; 80(12):1221-1228. PubMed ID: 33293730 [TBL] [Abstract][Full Text] [Related]
9. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study. Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408 [TBL] [Abstract][Full Text] [Related]
10. Unilateral groin and pelvic irradiation for unilaterally node-positive women with vulval carcinoma. Jackson KS; Fankam EF; Das N; Naik R; Lopes AD; Godfrey KA; Hatem MH; Branson AN; Taylor WT Int J Gynecol Cancer; 2006; 16(1):283-7. PubMed ID: 16445646 [TBL] [Abstract][Full Text] [Related]
11. Clinical implication of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes. Klemm P; Marnitz S; Köhler C; Braig U; Schneider A Gynecol Oncol; 2005 Oct; 99(1):101-5. PubMed ID: 15982723 [TBL] [Abstract][Full Text] [Related]
12. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection. Fonseca-Moutinho JA; Coelho MC; Silva DP J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system. Baiocchi G; Silva Cestari FM; Rocha RM; Lavorato-Rocha A; Maia BM; Cestari LA; Kumagai LY; Faloppa CC; Fukazawa EM; Badiglian-Filho L; Sant'ana Rodrigues I; Soares FA Eur J Surg Oncol; 2013 Jul; 39(7):780-5. PubMed ID: 23518307 [TBL] [Abstract][Full Text] [Related]
14. Preoperative predictors of inguinal lymph node metastases in vulvar cancer - A nationwide study. Schnack TH; Froeding LP; Kristensen E; Niemann I; Ørtoft G; Høgdall E; Høgdall C Gynecol Oncol; 2022 Jun; 165(3):420-427. PubMed ID: 35483986 [TBL] [Abstract][Full Text] [Related]
15. Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva. Gonzalez Bosquet J; Magrina JF; Magtibay PM; Gaffey TA; Cha SS; Jones MB; Podratz KC; Cliby WA Gynecol Oncol; 2007 Jun; 105(3):742-6. PubMed ID: 17379281 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided FNA cytology of groin lymph nodes improves the management of squamous cell carcinoma of the vulva: Results from a comparative cytohistological study. Angelico G; Santoro A; Inzani F; Spadola S; Fiorentino V; Cianfrini F; Carbone C; Garganese G; Rossi ED; Scambia G; Zannoni GF Cancer Cytopathol; 2019 Aug; 127(8):514-520. PubMed ID: 31174235 [TBL] [Abstract][Full Text] [Related]
17. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gordinier ME; Malpica A; Burke TW; Bodurka DC; Wolf JK; Jhingran A; Ramirez PT; Levenback C Gynecol Oncol; 2003 Sep; 90(3):625-8. PubMed ID: 13678736 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic implications of lymph nodal spread in lateral T1 and T2 squamous cell carcinoma of the vulva. Andrews SJ; Williams BT; DePriest PD; Gallion HH; Hunter JE; Buckley SL; Kryscio RJ; van Nagell JR Gynecol Oncol; 1994 Oct; 55(1):41-6. PubMed ID: 7959264 [TBL] [Abstract][Full Text] [Related]
19. Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva. Swift BE; Khoja L; Matthews J; Croke J; Laframboise S; Leung E; Gien LT Gynecol Oncol; 2024 Aug; 187():46-50. PubMed ID: 38723339 [TBL] [Abstract][Full Text] [Related]
20. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers. Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]